Verition Fund Management’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-33,180
Closed -$110K 3646
2025
Q1
$110K Buy
33,180
+22,320
+206% +$106K ﹤0.01% 3145
2024
Q4
$67.1K Sell
10,860
-15,255
-58% -$88.6K ﹤0.01% 3112
2024
Q3
$146K Sell
26,115
-14,511
-36% -$96.8K ﹤0.01% 2949
2024
Q2
$303K Buy
+40,626
New +$251K ﹤0.01% 2341
2022
Q2
Sell
-106,936
Closed -$1.06M 2401
2022
Q1
$1.06M Hold
106,936
0.01% 1419
2021
Q4
$1.05M Buy
+106,936
New +$1.04M 0.01% 1267
2021
Q3
Sell
-228,100
Closed -$2.21M 1931
2021
Q2
$2.21M Buy
+228,100
New +$2.24M 0.02% 498

Other funds holding BTMD

Verition Fund Management's BTMD Position: Q2 2025 in Review

Verition Fund Management sold out of Biote Corp (BTMD) in Q2 2025, closing a stake of 33,180 shares — an estimated $110K sold.

Verition Fund Management first reported a position in BTMD in Q2 2021 and held it in 7 quarters. The position peaked at $2.21M in Q2 2021. 97 funds tracked by Wall St. Rank hold BTMD as of Q2 2025.

  • Verition Fund Management reported no remaining Biote Corp position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 33,180 Biote Corp shares in Q2 2025, an estimated $110K.
  • Verition Fund Management first reported a position in Biote Corp in Q2 2021 and held it in 7 quarters.
  • Verition Fund Management's Biote Corp position peaked at $2.21M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Biote Corp as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.